BRIEF published on 07/30/2025 at 10:04, 1 year 1 month ago Medartis to Present 2025 Half-Year Results in Webcast Medical Devices Webcast Half-year Results Q&A Session Medartis
BRIEF published on 07/30/2025 at 10:04, 1 year 1 month ago Medartis présentera ses résultats semestriels 2025 en webcast Résultats Semestriels Webcast Dispositifs Médicaux Medartis Séance De Questions-réponses
PRESS RELEASE published on 07/30/2025 at 09:59, 1 year 1 month ago Medartis 2025 half-year results webcast Medartis Holding AG to present 2025 half-year results via webcast on August 19, 2025. CEO Matthias Schupp and CFO Dirk Kirsten to speak. Event details and registration link provided Webcast Medartis Holding AG Dirk Kirsten Matthias Schupp 2025 Half-Year Results
BRIEF published on 07/17/2025 at 07:04, 1 year 1 month ago Medartis Finalizes Full Acquisition of KeriMedical FDA Approval Medartis Acquisition KeriMedical Joint Replacement TOUCH Prosthesis
BRIEF published on 07/17/2025 at 07:04, 1 year 1 month ago Medartis finalise l'acquisition complète de KeriMedical Approbation De La FDA KeriMedical Acquisition De Medartis Remplacement Articulaire Prothèse TOUCH
PRESS RELEASE published on 07/17/2025 at 06:59, 1 year 1 month ago Medartis acquires remaining 53% stake in KeriMedical Medartis acquires remaining 53% stake in KeriMedical, strengthening position in joint replacement & expanding surgeon network. Acquisition valued at CHF 99 million in cash with FDA-approved flagship product TOUCH Acquisition FDA Approval Medartis KeriMedical Joint Replacement
PRESS RELEASE published on 03/18/2025 at 06:59, 1 year 5 months ago Medartis delivers 12% core sales growth in 2024 and improves its core EBITDA margin from 17% to 19%
PRESS RELEASE published on 08/20/2024 at 07:05, 2 years ago Medartis reports 13% revenue growth on Group level, driven by strong regional growth in the US (21%) and EMEA (18%) –improvement of EBITDA* margin to 17%
BRIEF published on 07/09/2024 at 07:04, 2 years 1 month ago Matthias Schupp nommé PDG de Medartis Technologie Médicale Nomination Du PDG Medartis Matthias Schupp
BRIEF published on 07/09/2024 at 07:04, 2 years 1 month ago Matthias Schupp Appointed as CEO of Medartis Medical Technology CEO Appointment Medartis Matthias Schupp
Published on 09/01/2026 at 16:10, 2 hours 3 minutes ago Sparton Signs Definitive Morrison Silver Mine Option and Joint Venture Agreement with Glen Eagle; Appoints Vice President, Corporate Development
Published on 09/01/2026 at 15:40, 2 hours 33 minutes ago Norsemont Provides Choquelimpie Drilling Update
Published on 09/01/2026 at 15:30, 2 hours 43 minutes ago Caldwell Launches Global Financial Institutions Group Practice
Published on 09/01/2026 at 14:31, 3 hours 42 minutes ago First Breach Expands Ammunition Manufacturing Capacity with Installation of New Loading and Inspection Equipment
Published on 09/01/2026 at 14:00, 4 hours 13 minutes ago Horizon Aircraft Advances All-Weather Certification Path with the Start of Ice Protection Technology Testing
Published on 09/01/2026 at 18:01, 12 minutes ago Gerresheimer AG: Annual General Meeting Approves the Company's Proposed Resolutions by a Majority Vote
Published on 09/01/2026 at 17:35, 38 minutes ago Aurzen Launches EAZZE E1 and E1R at IFA 2026, Bringing Smart Big-Screen Entertainment to Everyday Spaces
Published on 09/01/2026 at 17:44, 29 minutes ago Reporting on share buyback transactions carried out between August 18 and August 28, 2026
Published on 09/01/2026 at 17:44, 29 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain entre le 18 et le 28 août 2026
Published on 09/01/2026 at 17:39, 34 minutes ago Déclaration hebdomadaire d'opérations effectuées du 31 août 2026
Published on 09/01/2026 at 17:39, 34 minutes ago Disclosure of transactions in own shares of 31 August, 2026
